Skip to content

Genetic abnormalities in myeloproliferative neoplasms

Genetic abnormalities in myeloproliferative neoplasms - Genetic abnormalities in MPNs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000016132
Enrollment
50
Registered
2015-01-07
Start date
2014-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myeloproliferative neoplasms

Interventions

None listed

Sponsors

Mie University, Department of Hematology and Oncology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: myeloproliferative neoplasms

Exclusion criteria

Exclusion criteria: Patients without informed consent

Design outcomes

Primary

MeasureTime frame
frequencies of each genetic abnormalities, clinical presentations, prognosis in myeloproliferative neoplasms

Countries

Japan

Contacts

Public ContactYuka Sugimoto

Mie University Department of Hematology and Oncology

yuka2@clin.medic.mie-u.ac.jp059-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026